Bruce Linton, current non-executive director of Auscann Group Holdings, has appointed David Pryce as his alternate director. Mr Pryce is vice president of international market expansion and global government relations at Canopy Growth Corporation, the largest cannabinoid medicine producer in North America. Auscann has also appointed Dr Danial Schecter, chief medical officer at Cannabinoid Medical Clinic in Toronto, as chief medical advisor.
© Business News 2017. You may share content using the tools provided but do not copy and redistribute.